{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-095146","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2026-08-28T21:00:16+00:00","discovered_at":"2026-08-28T21:02:01.824194+00:00","generated_at":"2026-08-28T21:02:09.772582+00:00","sec_items":["8.01","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BiomX announces 1-for-10 reverse stock split, effective September 9, 2026","bullets":["Stockholders approved reverse split at Aug 25 special meeting; Board fixed ratio at 1-for-10 on Aug 28.","Authorized shares cut from 750M to 150M; outstanding shares reduce from ~26.7M to ~2.7M.","Split effective 12:01 a.m. ET Sept 9; trading on NYSE American split-adjusted when market opens.","No fractional shares; holders receive rounded-up whole shares; CUSIP changes to 09090D 608.","Warrants, convertible instruments, and equity awards adjusted proportionally."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-095146","json":"https://secwatch.observer/filing/0001213900-26-095146.json","markdown":"https://secwatch.observer/filing/0001213900-26-095146.md","text":"https://secwatch.observer/filing/0001213900-26-095146.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026095146/0001213900-26-095146-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026095146/ea0303593-8k_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-28T21:02:09.772582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}